Abstract
Following cardiac surgery many patients require hemodynamic assistance with inotropic or vasoconstrictive support. The most commonly used inotropes are catecholamines, but phosphodiesterase inhibitors or calcium sensitizers have been shown to be effective and indicated in specific patients. For patients with postoperative vasoplegic shock, catecholamines function as vasopressors to increase systemic vascular resistance and mean arterial pressure. In catecholamine resistant shock, vasopressin may be utilized. In severe, life-threatening shock, methylene blue has shown efficacy in improving hemodynamics and decreasing need for vasoconstrictors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tarvasmäki T, Lassus J, Varpula M, et al. Current real-life use of vasopressors and inotropes in cardiogenic shock – adrenaline use is associated with excess organ injury and mortality. Crit Care. 2016;20:208–18.
Bastien O, Vallet B. French multicenter survey on the use of inotropes after cardiac surgery. Crit Care. 2005;9:241–2.
Kastrup M, Markewitz A, Spies C, et al. Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: results from a postal surgery. Acta Anaesthesiol Scand. 2007;51:347–58.
Arrigo M, Mebazaa A. Understanding the differences among inotropes. Intensive Care Med. 2015;41:912–5.
Gillies M, Bellomo R, Doolan L, et al. Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery – a systemic literature review. Crit Care. 2005;9(3):266–79.
Belletti A, Castro ML, Silvetti S, et al. The effect of inotropes and vasopressors on mortality: a meta-analysis of randomized clinical trials. Br J Anaesth. 2015;115(5):656–75.
Levy B, Bastien O, Bendjelid K, et al. Experts’ recommendations for the management of adult patients with cardiogenic shock. Ann Intensive Care. 2015;5:17–26.
Levy B, Perez P, Perny J, et al. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective randomized pilot study. Crit Care Med. 2011;39(3):450–5.
Butterworth JF, Prielipp RC, Royster RL, et al. Dobutamine increases heart rate more than epinephrine in patient recovering from aortocoronary bypass surgery. J Cardiothorac Vasc Anesth. 1992;6:535–41.
Hui-li G. The management of acute pulmonary hypertension. Cardiovasc Ther. 2011;29:153–75.
Costanzo MR, Dipchand AM, Starling R, et al. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients. J Heart Lung Transplant. 2010;29:914–56.
Papp Z, Édes I, Fruhwald S, et al. Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan. Int J Cardiol. 2012;159:82–7.
Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomized double blind trial. Lancet. 2002;360:196–202.
Landoni G, Lomivorotov VV, Alvaro G, et al. Levosimendan for hemodynamic support after cardiac surgery. N Engl J Med. 2017;376(21):2021–31.
Mehta RH, Leimberger JD, van Diepen S, et al. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med. 2017;376(21):2032–42.
Erb J, Beutlhauser T, Feldheiser A, et al. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery. J Int Med Res. 2014;42(3):750–64.
Salgado Filho MF, Barral M, Barrucand L, et al. A randomized blinded study of the left ventricular myocardial performance index comparing epinephrine to levosimendan following cardiopulmonary bypass. PLoS One. 2015;10(12):1–16. Web.
Mishra A, Kumar B, Dutta V, et al. Comparative effect of levosimendan and milrinone in cardiac surgery patients with pulmonary hypertension and left ventricular dysfunction. J Cardiothorac Vasc Anesth. 2016;30(3):639–46.
Boyle EM Jr, Pohlman TH, Johnson MC, et al. Endothelial cell injury in cardiovascular surgery: the systemic inflammatory response. Ann Thorac Surg. 1997;63:277–84.
Argenziano M, Chen JM, Choudhri AF, et al. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998;116(6):973–80.
Hajjar LA, Vincent JL, Barbosa Gomes Galas FR, et al. Vasopressin versus norepinephrine in patients with vasoplegic shock and cardiac surgery. Anesthesiology. 2017;126:85–93.
Egi M, Bellomo R, Langenberg C, et al. Selecting a vasopressor drug for vasoplegic shock after adult cardiac surgery: a systematic literature review. Ann Thorac Surg. 2007;83:715–23.
De Backer D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362(9):779–89.
Feddersen K, Aurell M, Delin K, et al. Effect of cardiopulmonary bypass and prostacyclin on plasma catecholamines, angiotensin II and arginine vasopressin. Acta Anaesthesiol Scand. 1985;29:224–30.
Leyh RG, Kofidis T, Strüber M, et al. Methylene blue: the drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg. 2003;125:1426–31.
Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004;77:496–9.
Mazzeffi M, Hammer B, Chen E, et al. Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: a cohort study. Ann Card Anaesth. 2017;20(2):178–81.
Mehaffey JH, Johnston LE, Hawkins RB, et al. Methylene blue for vasoplegic syndrome after cardiac operation: early administration improves survival. Ann Thorac Surg. 2017;104(1):36–41.
Özal E, Kuralay E, Yildirim V, et al. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005;79:1615–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Dalton, A. (2019). Inotropes and Vasopressors in the CT ICU: Getting the Mixture Right. In: Lonchyna, V. (eds) Difficult Decisions in Cardiothoracic Critical Care Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach. Springer, Cham. https://doi.org/10.1007/978-3-030-04146-5_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-04146-5_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-04145-8
Online ISBN: 978-3-030-04146-5
eBook Packages: MedicineMedicine (R0)